BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/20/2023 4:48:37 PM | Browse: 144 | Download: 411
Publication Name World Journal of Clinical Cases
Manuscript ID 85084
Country China
Received
2023-04-21 07:30
Peer-Review Started
2023-04-21 07:33
To Make the First Decision
Return for Revision
2023-05-19 02:24
Revised
2023-06-24 14:50
Second Decision
2023-07-28 02:44
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2023-07-28 07:27
Articles in Press
2023-07-28 07:27
Publication Fee Transferred
Edit the Manuscript by Language Editor
2023-08-05 23:43
Typeset the Manuscript
2023-09-12 06:12
Publish the Manuscript Online
2023-09-20 16:48
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Pharmacology & Pharmacy
Manuscript Type Clinical and Translational Research
Article Title Exploring the pharmacological mechanism of Wuzhuyu decoction on hepatocellular carcinoma using network pharmacology
Manuscript Source Unsolicited Manuscript
All Author List Jia-Ying Ouyang, Wei-Jie Lin, Jia-Mei Dong, Yang Yang, Hai-Kui Yang, Zhi-Ling Zhou and Rui-Qi Wang
ORCID
Author(s) ORCID Number
Rui-Qi Wang http://orcid.org/0000-0002-4075-8815
Funding Agency and Grant Number
Funding Agency Grant Number
Xiangshan Talented Scientific Research Project of Zhuhai People’s Hospital 2021XSYC-02
Research Start Project of Zhuhai People’s Hospital 2020ycqd001
Corresponding Author Rui-Qi Wang, PhD, Lecturer, Department of Pharmacy, Zhuhai People’s Hospital (Zhuhai Hospital Affiliated with Jinan University), No. 79 Corning Road, Zhuhai 519000, Guangdong Province, China. wangrq2020@ext.jnu.edu.cn
Key Words Wuzhuyu decoction; Hepatocellular carcinoma; Network pharmacology; Pharmacological mechanism; Bioinformatics
Core Tip After screening, 6 main active components (Quercetin, Kaempferol, Ginsenoside Rh2, Rutaecarpine, Beta-carotene and Beta-sitosterol) and 10 core genes (tumor necrosis factor, interleukin-6, AKT1, TP53, caspase-3, mitogen-activated protein kinase 1, epidermal growth factor receptor, MYC, MAPK8, JUN) were obtained from Wuzhuyu decoction, and 179 pathways were obtained from Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis, which indicates that multi-component, multi-target and multi-pathway are the mechanism characteristics of Wuzhuyu decoction treating hepatocellular carcinoma (HCC). The active components of Wuzhuyu decoction may participate in these pathways by acting on the top 10 hub genes, which achieves the therapeutic effect of HCC.
Publish Date 2023-09-20 16:48
Citation Ouyang JY, Lin WJ, Dong JM, Yang Y, Yang HK, Zhou ZL, Wang RQ. Exploring the pharmacological mechanism of Wuzhuyu decoction on hepatocellular carcinoma using network pharmacology. World J Clin Cases 2023; 11(27): 6327-6343
URL https://www.wjgnet.com/2307-8960/full/v11/i27/6327.htm
DOI https://dx.doi.org/10.12998/wjcc.v11.i27.6327
Full Article (PDF) WJCC-11-6327-with-cover.pdf
Full Article (Word) WJCC-11-6327.docx
Manuscript File 85084-Review-FilipodiaCL.docx
Answering Reviewers 85084-Answering reviewers.pdf
Audio Core Tip 85084-Audio core tip.m4a
Biostatistics Review Certificate 85084-Biostatistics statement.pdf
Clinical Trial Registration Statement 85084-Clinical trial registration statement.pdf
Conflict-of-Interest Disclosure Form 85084-Conflict-of-interest statement.pdf
Copyright License Agreement 85084-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 85084-Grant application form(s).pdf
Signed Informed Consent Form(s) or Document(s) 85084-Informed consent statement.pdf
Institutional Review Board Approval Form or Document 85084-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate 85084-Language certificate.pdf
Supplementary Material 85084-Supplementary material.pdf
Peer-review Report 85084-Peer-review(s).pdf
Scientific Misconduct Check 85084-Bing-Wang JJ-2.png
Scientific Editor Work List 85084-Scientific editor work list.pdf
CrossCheck Report 85084-CrossCheck report.pdf